Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling
Abstract
CTNNB1, the gene encoding β-catenin, is a frequent target for oncogenic mutations activating the canonical Wnt signaling pathway, typically through missense mutations within a degron hotspot motif in exon 3. Here, we combine saturation genome editing with a fluorescent reporter assay to quantify signaling phenotypes for all 342 possible missense mutations in the mutation hotspot. Our data define the genetic requirements for β-catenin degron function, refine the consensus motif for substrate recognition by β-TRCP and reveal diverse levels of signal activation among known driver mutations. Tumorigenesis in different human tissues involves selection for CTNNB1 mutations spanning distinct ranges of predicted activity. In hepatocellular carcinoma, mutation effect scores distinguish two tumor subclasses with different levels of β-catenin signaling, and weaker mutations predict greater immune cell infiltration in the tumor microenvironment. Our work provides a resource to understand mutational diversity within a pan-cancer mutation hotspot, with potential implications for targeted therapy.
Fields of Study & Subjects
Wnt/β-catenin signaling in development and cancer
Cancer Cells and Metastasis
Cancer-related Molecular Pathways
Publication details
- Journal / source
- Nature Genetics
- Publisher
- Springer Science and Business Media LLC
- Volume
- 58
- Issue
- 2
- Pages
- 366–375
- Publication date
- 1 February 2026
- Language
- EN